2021 Annual Scientific Sessions
15.50 (CME)
September 24, 2021
Optimizing LDL-C Reduction with Oral Therapy: Featuring the Wheel of Knowledge Challenge- Vindico Sympo
1.50 (CME)
September 25, 2021
2020 Virtual Scientific Sessions Live
14.50 (CME)
December 10, 2020
Mastering the Management of Hyperlipidemia in Statin-Treated or Statin-Intolerant Patients: Recent Treatment Advances for Patients That Remain at High Risk of ASCVD- PVI
1.50 (CME)
December 12, 2020
Genetic Dyslipidemias: Familial Hypercholesterolemia & Beyond
1.50 (CME)
December 11, 2020
The Ever-Evolving Treatment Landscape of Lipid-Lowering Therapies hosted by Medscape
1.50 (CME)
December 11, 2020
Dialogues from the Dais: Lipid Management in Clinical Medicine- Medtelligence Symposium
1.50 (CME)
June 4, 2020
Bridging the Gaps in Management of Familial Chylomicronemia Syndrome: A Team-Based Patient-Focused Approach
0.50 (CME)
December 13, 2020
2019 Scientific Sessions
13.00 (CME)
May 16, 2019
2018 Scientific Sessions
18.75 (CME)
April 26, 2018
Severe/Resistant Hypercholesterolemia: Clinical Trials, Lessons Learned, and Outcomes Explored
1.50 (CME)
August 12, 2017
Early Detection, Early Intervention: Best Practices in the Management of Homozygous Familial Hypercholesterolemia Symposia
1.50 (CME)
May 19, 2017
Optimizing Patient Outcomes in the Era of PCSK9 Inhibitor Therapeutics
2.00 (CME)
May 18, 2017
NLA-SAP Volume 5- 2016 Edition IV
16.25 (CME)
November 15, 2016
NLA-SAP Volume 1- 2016 Edition IV
12.00 (CME)
November 15, 2016
Lipid Management Beyond Statins: Biologic Basis New Clinical Evidence and Strategies
2.25 (CME)
June 12, 2015
Beyond Statin Therapy: A Comprehensive Approach to Dyslipidemia Management
1.25 (CME)
June 12, 2015
Effective Management of Homozygous Familial Hypercholesterolemia: Therapeutic Strategies for Complex Dyslipidemia
1.50 (CME)
June 11, 2015
Insights Into Vascular and Antioxidant Effects of EPA Relevant to Atherogenesis
1.00 (CME)
June 13, 2015
2015 Annual Scientific Sessions- Chicago, IL
19.50 (CME)
June 11, 2015
Advancing Therapy in the Severe FH Patient- Fall CLU Symposium
1.50 (CME)
August 23, 2014
2014 Clinical Lipid Update- Staying on Track with Lipid Management: Translating the Guidelines into Practice
12.25 (CME)
August 22, 2014
2014 Annual Scientific Sessions- Orlando
20.00 (CME)
May 1, 2014
Integrating Obesity & Dyslipidemia Management to Reduce Atherosclerotic Disease
2.00 (CME)
May 2, 2014
2013 National Lipid Association Scientific Sessions
14.75 (CME)
May 29, 2013
CLMSAP 14 Evaluation and Management of Familial Hypercholesterolemia
3.00 (CME)
January 28, 2011
2011 NLA Annual Scientific Sessions
20.00 (CME)
May 19, 2011
2010 NLA Annual Scientific Sessions MWLA in conjunction with NLA
7.75 (CME)
May 13, 2010
FH Symposium: Screening and Treatment of Familial Hypercholesterolemia: How Can We Do Better?
1.50 (CME)
May 15, 2010
3rd NLA Summit on HDL Therapeutics
4.50 (CME)
May 14, 2010
CLM SAP 13 Challenging Cases
2.50 (CME)
May 1, 2009
NLA-SSM for Primary Care #1: Focus on Combination Therapies (online module)
5.00 (CME)
May 1, 2009
NLA-SSM #2- Pharmacology and Safety of Lipid-AlteringTherapies (online module)
6.00 (CME)
May 1, 2009
CLM-SAP #11: Clinical Applications of Advanced Lipoprotein Testing, Inflammatory Markers and Non-invasive Assessments of Atherosclerosis (online module)
6.00 (CME)
May 1, 2009
CLM-SAP #12: Management of Low HDL-C (online module)
5.00 (CME)
May 1, 2009
NLA/SAP Volume 4 - 2008 Update
40.00 (CME)
June 1, 2008
NLA/SAP Volume 3 - 2008 Update
35.00 (CME)
June 1, 2008
NLA/SAP Volume 2 - 2008 Update
35.00 (CME)
June 1, 2008
NLA/SAP Volume 1 - 2008 Update
40.00 (CME)
June 1, 2008
Masters in Lipidology at MWLA 2008
15.00 (CME)
September 25, 2008
CLM-SAP #12-Low HDL
5.00 (CME)
January 1, 2007
.jpg)
.png)
